Gluten Exorphin B5

CAS No. 68382-18-3

Gluten Exorphin B5( —— )

Catalog No. M30513 CAS No. 68382-18-3

Gluten exorphin B5 (GE-B5) is a food-derived opioid peptide identified in digests of wheat gluten.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote

Biological Information

  • Product Name
    Gluten Exorphin B5
  • Note
    Research use only, not for human use.
  • Brief Description
    Gluten exorphin B5 (GE-B5) is a food-derived opioid peptide identified in digests of wheat gluten.
  • Description
    Gluten exorphin B5 (GE-B5) is a food-derived opioid peptide identified in digests of wheat gluten.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    Opioid receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    68382-18-3
  • Formula Weight
    594.66
  • Molecular Formula
    C30H38N6O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    Sequence:{Tyr}{Gly}{Gly}{Trp}{Leu}

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Fukudome S, et al. Effect of gluten exorphins A5 and B5 on the postprandial plasma insulin level in conscious rats. Life Sci. 1995;57(7):729-34.
molnova catalog
related products
  • [Leu5]-Enkephalin

    [Leu5]-Enkephalin is an endogenous neuropeptide involved in nociception and an agonist of δ-opioid and μ-opioid receptors (Kis = 4.0 and 3.4 nM respectively).

  • ORL1 antagonist 1

    ORL1 antagonist 1 is an o antagonist of pioid receptor-like 1 (ORL1) (IC50 of 61 nM).

  • Hemorphin-7

    Hemorphin-7 binds to the angiotensin IV receptor, triggering multiple effects including cellular proliferation and memory enhancement. Hemorphins are endogenous peptides belonging to the family of atypical opioid peptides released from hydrolyzed hemoglobin. Hemorphin-7 is investigated as a potential biomarker for breast cancer.